Works matching AU Papp, Kim A.

Results: 175
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Deucravacitinib in plaque psoriasis: Four‐year safety and efficacy results from the Phase 3 POETYK PSO‐1, PSO‐2 and long‐term extension trials.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 7, p. 1336, doi. 10.1111/jdv.20553
    By:
    • Armstrong, April W.;
    • Lebwohl, Mark;
    • Warren, Richard B.;
    • Sofen, Howard;
    • Morita, Akimichi;
    • Paul, Carle;
    • Papp, Kim A.;
    • Colombo, Matthew J.;
    • Scotto, Julie;
    • Vaile, John;
    • Zhuo, Joe;
    • Vritzali, Eleni;
    • Berger, Victoria;
    • Schroeder, Georgene;
    • Banerjee, Subhashis;
    • Thaçi, Diamant;
    • Strober, Bruce
    Publication type:
    Article
    11

    Considerations for defining and diagnosing generalized pustular psoriasis.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 3, p. 487, doi. 10.1111/jdv.20310
    By:
    • Prajapati, Vimal H.;
    • Lynde, Charles W.;
    • Gooderham, Melinda J.;
    • Hong, H. Chih‐ho;
    • Kirchhof, Mark G.;
    • Lansang, Perla;
    • Ringuet, Julien;
    • Turchin, Irina;
    • Vender, Ron;
    • Yeung, Jensen;
    • Papp, Kim A.
    Publication type:
    Article
    12

    Deucravacitinib in moderate‐to‐severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO‐1 and PSO‐2).

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 8, p. 1543, doi. 10.1111/jdv.19925
    By:
    • Strober, Bruce;
    • Blauvelt, Andrew;
    • Warren, Richard B.;
    • Papp, Kim A.;
    • Armstrong, April W.;
    • Gordon, Kenneth B.;
    • Morita, Akimichi;
    • Alexis, Andrew F.;
    • Lebwohl, Mark;
    • Foley, Peter;
    • Kisa, Renata M.;
    • Colston, Elizabeth;
    • Wang, Tao;
    • Banerjee, Subhashis;
    • Thaçi, Diamant
    Publication type:
    Article
    13

    Upadacitinib treatment withdrawal and retreatment in patients with moderate‐to‐severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 12, p. 2558, doi. 10.1111/jdv.19391
    By:
    • Guttman‐Yassky, Emma;
    • Silverberg, Jonathan I.;
    • Thaçi, Diamant;
    • Papp, Kim A.;
    • Ständer, Sonja;
    • Beck, Lisa A.;
    • Kim, Brian S.;
    • Hu, Xiaofei;
    • Liu, Jianzhong;
    • Calimlim, Brian M.;
    • Vigna, Namita;
    • Crowley, Jameson T.;
    • Teixeira, Henrique D.;
    • Thyssen, Jacob P.
    Publication type:
    Article
    14
    15

    Abrocitinib efficacy and safety in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 10, p. 2056, doi. 10.1111/jdv.19280
    By:
    • Reich, Kristian;
    • Silverberg, Jonathan I.;
    • Papp, Kim A.;
    • Deleuran, Mette;
    • Katoh, Norito;
    • Strober, Bruce;
    • Beck, Lisa A.;
    • de Bruin‐Weller, Marjolein;
    • Werfel, Thomas;
    • Zhang, Fan;
    • Biswas, Pinaki;
    • DiBonaventura, Marco D.;
    • Chan, Gary;
    • Johnson, Susan;
    • Farooqui, Saleem A.;
    • Kerkmann, Urs;
    • Clibborn, Claire
    Publication type:
    Article
    16
    17
    18
    19

    Canadian Consensus Guidelines for the Management of Vitiligo.

    Published in:
    Dermatology & Therapy, 2025, v. 15, n. 6, p. 1351, doi. 10.1007/s13555-025-01402-5
    By:
    • Prajapati, Vimal H.;
    • Lui, Harvey;
    • Miller-Monthrope, Yvette;
    • Ringuet, Julien;
    • Turchin, Irina;
    • Hong, H. Chih-ho;
    • Lynde, Charles;
    • Papp, Kim A.;
    • Yeung, Jensen;
    • Gooderham, Melinda J.
    Publication type:
    Article
    20
    21
    22

    Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months.

    Published in:
    Dermatology & Therapy, 2025, v. 15, n. 2, p. 381, doi. 10.1007/s13555-025-01342-0
    By:
    • Thaçi, Diamant;
    • Ohtsuki, Mamitaro;
    • Maul, Julia-Tatjana;
    • Szegedi, Andrea;
    • Luna, Paula C.;
    • Lynde, Charles W.;
    • Soliman, Ahmed M.;
    • Wang, Hongwei;
    • Kaufmann, Christian;
    • Ashley, Doug G.;
    • Madihlaba, Tshepiso;
    • Rubant, Simone;
    • Papp, Kim A.
    Publication type:
    Article
    23

    Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events.

    Published in:
    Dermatology & Therapy, 2025, v. 15, n. 1, p. 161, doi. 10.1007/s13555-024-01323-9
    By:
    • Lebwohl, Mark;
    • Deodhar, Atul;
    • Schwartzman, Sergio;
    • Salvarani, Carlo;
    • Feely McDonald, Meghan;
    • Bello, Natalia;
    • Grace, Elsie L.;
    • Inman, Elsa;
    • Kronbergs, Andris;
    • Ngantcha, Marcus;
    • Rahman, Proton;
    • Papp, Kim A.;
    • Merola, Joseph F.;
    • Gottlieb, Alice B.;
    • Blauvelt, Andrew
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30

    Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.

    Published in:
    Dermatology & Therapy, 2023, v. 13, n. 4, p. 867, doi. 10.1007/s13555-023-00905-3
    By:
    • Papp, Kim A.;
    • Melosky, Barbara;
    • Sehdev, Sandeep;
    • Hotte, Sebastien J.;
    • Beecker, Jennifer R.;
    • Kirchhof, Mark G.;
    • Turchin, Irina;
    • Dutz, Jan P.;
    • Gooderham, Melinda J.;
    • Gniadecki, Robert;
    • Hong, Chih-ho;
    • Lambert, Jo;
    • Lynde, Charles W.;
    • Prajapati, Vimal H.;
    • Vender, Ronald B.
    Publication type:
    Article
    31
    32

    Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data.

    Published in:
    Dermatology & Therapy, 2023, v. 13, n. 1, p. 269, doi. 10.1007/s13555-022-00849-0
    By:
    • Papp, Kim A.;
    • Gooderham, Melinda;
    • Dei-Cas, Ignacio;
    • LopezTello, Adriana;
    • Garcia-Rodriguez, Juan C.;
    • Taveras, Carmen Yris;
    • Rousselin, Azucena Hernández;
    • Lavieri, Alberto;
    • Maiolino, Mónica;
    • Quintero, Delfina Guadalupe Villanueva;
    • Rihakova, Lenka;
    • Salibe, Mariano;
    • Pertuz, Wilfran
    Publication type:
    Article
    33
    34

    Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.

    Published in:
    Dermatology & Therapy, 2022, v. 12, n. 5, p. 1073, doi. 10.1007/s13555-022-00722-0
    By:
    • Papp, Kim A.;
    • Beecker, Jennifer;
    • Cooper, Curtis;
    • Kirchhof, Mark G.;
    • Pozniak, Anton L.;
    • Rockstroh, Juergen K.;
    • Dutz, Jan P.;
    • Gooderham, Melinda J.;
    • Gniadecki, Robert;
    • Hong, Chih-ho;
    • Lynde, Charles W.;
    • Maari, Catherine;
    • Poulin, Yves;
    • Vender, Ronald B.;
    • Walmsley, Sharon L.
    Publication type:
    Article
    35

    Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial.

    Published in:
    Dermatology & Therapy, 2022, v. 12, n. 2, p. 495, doi. 10.1007/s13555-021-00649-y
    By:
    • Thaçi, Diamant;
    • Strober, Bruce;
    • Gordon, Kenneth B.;
    • Foley, Peter;
    • Gooderham, Melinda;
    • Morita, Akimichi;
    • Papp, Kim A.;
    • Puig, Lluís;
    • Menter, M. Alan;
    • Colombo, Matthew J.;
    • Elbez, Yedid;
    • Kisa, Renata M.;
    • Ye, June;
    • Napoli, Andrew A.;
    • Wei, Lan;
    • Banerjee, Subhashis;
    • Merola, Joseph F.;
    • Gottlieb, Alice B.
    Publication type:
    Article
    36
    37

    Practical Management of Patients with Atopic Dermatitis on Dupilumab.

    Published in:
    Dermatology & Therapy, 2021, v. 11, n. 5, p. 1805, doi. 10.1007/s13555-021-00586-w
    By:
    • Papp, Kim A.;
    • Hong, Chih-ho;
    • Lansang, M. Perla;
    • Turchin, Irina;
    • Adam, David N.;
    • Beecker, Jennifer R.;
    • Bissonnette, Robert;
    • Gooderham, Melinda J.;
    • Jack, Carolyn;
    • Joseph, Marissa;
    • Lynde, Charles W.;
    • Shear, Neil H.
    Publication type:
    Article
    38
    39
    40
    41

    Psoriasis Prevalence and Severity by Expert Elicitation.

    Published in:
    Dermatology & Therapy, 2021, v. 11, n. 3, p. 1053, doi. 10.1007/s13555-021-00518-8
    By:
    • Papp, Kim A.;
    • Gniadecki, Robert;
    • Beecker, Jennifer;
    • Dutz, Jan;
    • Gooderham, Melinda J.;
    • Hong, Chih-Ho;
    • Kirchhof, Mark G.;
    • Lynde, Chuck W.;
    • Maari, Catherine;
    • Poulin, Yves;
    • Vender, Ron B.
    Publication type:
    Article
    42
    43

    Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials.

    Published in:
    Dermatology & Therapy, 2020, v. 10, n. 3, p. 431, doi. 10.1007/s13555-020-00367-x
    By:
    • Leonardi, Craig;
    • Reich, Kristian;
    • Foley, Peter;
    • Torii, Hideshi;
    • Gerdes, Sascha;
    • Guenther, Lyn;
    • Gooderham, Melinda;
    • Ferris, Laura K.;
    • Griffiths, Christopher E. M.;
    • ElMaraghy, Hany;
    • Crane, Heidi;
    • Patel, Himanshu;
    • Burge, Russel;
    • Gallo, Gaia;
    • Shrom, David;
    • Leung, Ann;
    • Lin, Chen-Yen;
    • Papp, Kim
    Publication type:
    Article
    44
    45
    46

    Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure.

    Published in:
    Dermatology & Therapy, 2020, v. 10, n. 1, p. 133, doi. 10.1007/s13555-019-00340-3
    By:
    • Armstrong, April;
    • Paul, Carle;
    • Puig, Luis;
    • Boehncke, Wolf Henning;
    • Freeman, Michael;
    • Torii, Hideshi;
    • Papp, Kim;
    • Griffiths, Christopher E. M.;
    • Blauvelt, Andrew;
    • Reich, Kristian;
    • Gooderham, Melinda;
    • Terui, Tadashi;
    • Renda, Lisa;
    • Agada, Noah;
    • Xu, Wen;
    • Gallo, Gaia;
    • Lebwohl, Mark G.
    Publication type:
    Article
    47
    48
    49
    50